-
RIGL Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Rigel Pharmaceuticals (RIGL)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 51.69 mm | 51.69 mm | 51.69 mm | 51.69 mm | 51.69 mm | 51.69 mm |
Cash burn (monthly) | (no burn) | (no burn) | (no burn) | (no burn) | 61.33 k | 1.07 mm |
Cash used (since last report) | n/a | n/a | n/a | n/a | 171.58 k | 2.98 mm |
Cash remaining | n/a | n/a | n/a | n/a | 51.52 mm | 48.71 mm |
Runway (months of cash) | n/a | n/a | n/a | n/a | 840.0 | 45.7 |
13F holders | Current |
---|---|
Total holders | 83 |
Opened positions | 20 |
Closed positions | 41 |
Increased positions | 3 |
Reduced positions | 57 |
13F shares | Current |
---|---|
Total value | 79.55 bn |
Total shares | 20.63 mm |
Total puts | 439.19 k |
Total calls | 383.88 k |
Total put/call ratio | 1.1 |
Largest owners | Shares | Value |
---|---|---|
Soleus Capital Master Fund | 9.22 mm | $14.67 mm |
Armistice Capital | 1.62 mm | $13.35 bn |
BLK BlackRock | 1.51 mm | $12.44 bn |
MS Morgan Stanley | 1.42 mm | $11.71 bn |
Soleus Capital Management | 1.04 mm | $8.58 bn |
Integrated Core Strategies | 1.03 mm | $3.60 mm |
Vanguard | 961.63 k | $7.90 bn |
Acadian Asset Management | 550.14 k | $4.52 mm |
Geode Capital Management | 390.78 k | $3.21 bn |
STT State Street | 365.24 k | $3.00 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
25 Nov 24 | David A Santos | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 18.7 | 8,000 | 149.60 k | 8,000 |
25 Nov 24 | Raul R Rodriguez | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 18.7 | 30,000 | 561.00 k | 30,000 |
25 Nov 24 | Dean L Schorno | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 18.7 | 6,250 | 116.88 k | 6,250 |
30 Aug 24 | Dean L Schorno | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 24.2 | 10,000 | 242.00 k | 10,000 |
30 Aug 24 | Raul R Rodriguez | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 24.2 | 32,500 | 786.50 k | 32,500 |